Dudediligence.

Hyperfine, Inc

HYPRNASDAQ · Electromedical & Electrotherapeutic Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.6MSep ’24$2.3MDec ’24$2.1MMar ’25$2.7MJun ’25$3.4MSep ’25$5.3MDec ’25$3.9MMar ’26$3.9MJun ’26
Net income, by quarter
−$10.3MSep ’24−$10.4MDec ’24−$9.4MMar ’25−$9.2MJun ’25−$11.0MSep ’25−$5.9MDec ’25−$8.6MMar ’26−$9.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.5M$6.8M$11.0M$12.9M$13.6M
Gross profit−$1.2M$907,000$4.8M$5.9M$6.8M
Operating income−$64.9M−$73.9M−$48.1M−$43.2M−$37.1M
Net income−$64.9M−$44.2M−$44.2M−$40.7M−$35.6M
Operating cash flow−$47.2M−$72.3M−$41.8M−$38.8M−$27.9M
Free cash flow−$49.9M−$72.9M−$42.6M−$39.1M−$29.1M
Cash$188.5M$117.5M$75.2M$37.6M$35.1M
Shares outstanding3.7M70.4M71.3M72.4M81.8M